Earnings ·
Dr. Reddy's posts Rs9.1B Q1 profit on Rs86.7B revenue
RDYDR Reddys Laboratories Ltd
Dr. Reddy’s Laboratories reported a net profit of Rs9.1 billion (U.S.$120 million) for the quarter ended September 30, 2026, down from Rs14.3 billion in the prior-year period. Revenue declined to Rs86.7 billion from Rs88.1 billion as cost of revenues rose to Rs41.5 billion. Operating profit fell to Rs12.7 billion from Rs17.5 billion due to higher selling, general and administrative expenses and research and development costs. The company operates in the pharmaceutical industry, developing and manufacturing generic medicines, biosimilars, and active pharmaceutical ingredients.